subject: UMLS:C5848411

subject_name: CDK4/6 Inhibitor G1T38

object_name: Childhood Breast Carcinoma


subject: UMLS:C5848411

object_name: breast carcinoma

tested_intervention: yes


subject: UMLS:C5848411

object_name: breast cancer


subject: UMLS:C5848411

object_name: breast neoplasm

tested_intervention: unsure


subject: UMLS:C5848411

object_name: invasive ductal breast carcinoma


subject: UMLS:C5848411

object_name: breast ductal adenocarcinoma


subject: CHEBI:38562

subject_name: Fluvastatin

object_name: hypertension


subject: CHEBI:38562

object_name: Hypertension, CTCAE


subject: CHEBI:38562

object_name: type 2 diabetes mellitus


subject: DRUGBANK:DB17204

object_name: small cell lung carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Hip dysplasia


subject: CHEBI:41879

object_name: Hip Dysplasia


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan

object_name: Nijmegen breakage syndrome


subject: UMLS:C3827106

object_name: Advanced cancer


subject: UMLS:C3490349

object_name: kidney failure


subject: UNII:7C00L34NB9

subject_name: Seladelpar

object_name: sclerosing cholangitis


subject: UNII:7C00L34NB9

object_name: primary sclerosing cholangitis


subject: UMLS:C3852696

object_name: Severe Malaria


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage III Distal Bile Duct Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Distal Bile Duct Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Distal Bile Duct Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Distal Bile Duct Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Intrahepatic Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: MESH:C520255

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: MESH:C520255

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:8081

subject_name: Phentolamine

object_name: obstructive sleep apnea syndrome


subject: UMLS:C5446887

subject_name: CDK4 Inhibitor PF-07220060

object_name: Well adult


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Neuropathic spinal arthropathy


subject: CHEBI:94518

object_name: Spinal Injuries


subject: PUBCHEM.COMPOUND:284240

object_name: brain cancer


subject: PUBCHEM.COMPOUND:284240

object_name: brain neoplasm


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18


subject: UNII:2X1K91UT6N


subject: UMLS:C2987342

object_name: liver carcinoma


subject: UMLS:C3896809

subject_name: HDM2 Inhibitor MK-8242

object_name: Solid Neoplasm


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: Vaso-occlusive pain episode in sickle cell disease


subject: UNII:IK51552IFH

subject_name: Zytron


subject: UNII:P8CL89W8AP


subject: CHEBI:229727

subject_name: DMPA zwitterion


subject: UNII:612K359T69

subject_name: ALVESPIMYCIN HYDROCHLORIDE

object_name: untreated metastatic squamous neck cancer with occult primary


subject: UNII:612K359T69

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: UNII:612K359T69

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UNII:612K359T69

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:612K359T69

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:612K359T69

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:612K359T69

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:612K359T69

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:612K359T69

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UNII:612K359T69

object_name: stage III midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:612K359T69

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UNII:612K359T69

object_name: stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:612K359T69

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UNII:612K359T69

object_name: stage III inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:612K359T69

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: UNII:612K359T69

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:612K359T69

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:612K359T69

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:612K359T69

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:612K359T69

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:612K359T69

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:612K359T69

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: UNII:612K359T69

object_name: Recurrent Lip Basal Cell Carcinoma


subject: UNII:612K359T69

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: UNII:612K359T69

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UNII:612K359T69

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UNII:612K359T69

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UNII:612K359T69

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UNII:612K359T69

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:612K359T69

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UNII:612K359T69

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UNII:612K359T69

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:612K359T69

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UNII:612K359T69

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: UNII:612K359T69

object_name: Laryngeal squamous cell carcinoma stage III


subject: UNII:612K359T69

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:612K359T69

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: UNII:612K359T69

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UNII:612K359T69

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:612K359T69


subject: UNII:612K359T69

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: UNII:612K359T69

object_name: Laryngeal verrucous carcinoma recurrent


subject: UNII:612K359T69

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: UNII:612K359T69

object_name: Stage III Lip Basal Cell Carcinoma


subject: UNII:612K359T69

object_name: Stage IV Lip Basal Cell Carcinoma


subject: UNII:612K359T69

object_name: Verrucous carcinoma of the oral cavity stage III


subject: UNII:612K359T69

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: UNII:612K359T69

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: UNII:612K359T69

object_name: Oropharyngeal lymphoepithelioma stage III


subject: UNII:612K359T69

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: UNII:612K359T69

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: UNII:612K359T69

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UNII:612K359T69

object_name: Laryngeal verrucous carcinoma stage III


subject: UNII:612K359T69

object_name: Laryngeal verrucous carcinoma stage IV


subject: UNII:612K359T69

object_name: Renal cell carcinoma recurrent


subject: UNII:612K359T69

object_name: Renal cancer recurrent


subject: UNII:612K359T69

object_name: Recurrent ovarian cancer


subject: UNII:612K359T69

object_name: Recurrent Salivary Gland Cancer


subject: UNII:612K359T69

object_name: Ovarian cancer stage III


subject: UNII:612K359T69

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UNII:612K359T69

object_name: Ovarian cancer stage IV


subject: UNII:612K359T69

object_name: Prostate cancer recurrent


subject: UNII:612K359T69

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UNII:612K359T69

object_name: Stage III renal cell cancer


subject: UNII:612K359T69

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UNII:612K359T69

object_name: Salivary gland cancer stage III


subject: UNII:612K359T69

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UNII:612K359T69

object_name: Stage IV Renal Cell Cancer


subject: UNII:612K359T69

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:612K359T69

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:612K359T69

object_name: Salivary gland cancer stage IV


subject: UNII:612K359T69

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UNII:612K359T69

object_name: recurrent gastric cancer


subject: UNII:612K359T69

object_name: Breast cancer recurrent


subject: UNII:612K359T69

object_name: Colon cancer recurrent


subject: UNII:612K359T69

object_name: Stage IV Prostate Cancer AJCC v6


subject: UNII:612K359T69

object_name: Carcinoma of the prostate stage IV


subject: UNII:612K359T69

object_name: Stage IV Prostate Cancer AJCC v7


subject: UNII:612K359T69

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:612K359T69

object_name: Melanoma recurrent


subject: UNII:612K359T69

object_name: Stage IIIB Breast Carcinoma


subject: UNII:612K359T69

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:612K359T69

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:612K359T69

object_name: Malignant neoplasm of stomach stage III


subject: UNII:612K359T69

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:612K359T69

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:612K359T69

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:612K359T69

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:612K359T69

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:612K359T69

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:612K359T69

object_name: Carcinoma breast stage IV


subject: UNII:612K359T69

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:612K359T69

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:612K359T69

object_name: Stage III Colon Cancer AJCC v7


subject: UNII:612K359T69

object_name: Stage III Colon Cancer AJCC v8


subject: UNII:612K359T69

object_name: Stage III Colon Cancer


subject: UNII:612K359T69

object_name: Stage IV Colon Cancer AJCC v8


subject: UNII:612K359T69

object_name: Stage IV Colon Cancer AJCC v6


subject: UNII:612K359T69

object_name: Stage IV Colon Cancer AJCC v7


subject: UNII:612K359T69

object_name: Malignant neoplasm of colon stage IV


subject: UNII:612K359T69

object_name: male breast carcinoma


subject: UNII:612K359T69

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:612K359T69

object_name: Metastatic Cutaneous Melanoma


subject: UNII:612K359T69

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:612K359T69

object_name: metastatic melanoma


subject: UMLS:C2698077

subject_name: Alvespimycin Hydrochloride

object_name: untreated metastatic squamous neck cancer with occult primary


subject: UMLS:C2698077

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: UMLS:C2698077

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UMLS:C2698077

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UMLS:C2698077

object_name: stage III squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C2698077

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UMLS:C2698077

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UMLS:C2698077

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: UMLS:C2698077

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C2698077

object_name: stage III midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UMLS:C2698077

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: UMLS:C2698077

object_name: stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UMLS:C2698077

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: UMLS:C2698077

object_name: stage III inverted papilloma of the paranasal sinus and nasal cavity


subject: UMLS:C2698077

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: UMLS:C2698077

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2698077

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2698077

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C2698077

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UMLS:C2698077

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C2698077

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UMLS:C2698077

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: UMLS:C2698077

object_name: Recurrent Lip Basal Cell Carcinoma


subject: UMLS:C2698077

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: UMLS:C2698077

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: UMLS:C2698077

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UMLS:C2698077

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UMLS:C2698077

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UMLS:C2698077

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2698077

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UMLS:C2698077

object_name: Metastatic Squamous Cell Carcinoma of the Oropharynx


subject: UMLS:C2698077

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2698077

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UMLS:C2698077

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: UMLS:C2698077

object_name: Laryngeal squamous cell carcinoma stage III


subject: UMLS:C2698077

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2698077

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: UMLS:C2698077

object_name: Metastatic Squamous Cell Carcinoma of the Larynx


subject: UMLS:C2698077

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2698077


subject: UMLS:C2698077

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: UMLS:C2698077

object_name: Laryngeal verrucous carcinoma recurrent


subject: UMLS:C2698077

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: UMLS:C2698077

object_name: Stage III Lip Basal Cell Carcinoma


subject: UMLS:C2698077

object_name: Stage IV Lip Basal Cell Carcinoma


subject: UMLS:C2698077

object_name: Verrucous carcinoma of the oral cavity stage III


subject: UMLS:C2698077

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: UMLS:C2698077

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: UMLS:C2698077

object_name: Oropharyngeal lymphoepithelioma stage III


subject: UMLS:C2698077

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: UMLS:C2698077

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: UMLS:C2698077

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: UMLS:C2698077

object_name: Laryngeal verrucous carcinoma stage III


subject: UMLS:C2698077

object_name: Laryngeal verrucous carcinoma stage IV


subject: UMLS:C2698077

object_name: Renal cell carcinoma recurrent


subject: UMLS:C2698077

object_name: Renal cancer recurrent


subject: UMLS:C2698077

object_name: Recurrent ovarian cancer


subject: UMLS:C2698077

object_name: Recurrent Salivary Gland Cancer


subject: UMLS:C2698077

object_name: Ovarian cancer stage III


subject: UMLS:C2698077

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2698077

object_name: Ovarian cancer stage IV


subject: UMLS:C2698077

object_name: Prostate cancer recurrent


subject: UMLS:C2698077

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C2698077

object_name: Stage III renal cell cancer


subject: UMLS:C2698077

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C2698077

object_name: Salivary gland cancer stage III


subject: UMLS:C2698077

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UMLS:C2698077

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C2698077

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C2698077

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C2698077

object_name: Salivary gland cancer stage IV


subject: UMLS:C2698077

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UMLS:C2698077

object_name: recurrent gastric cancer


subject: UMLS:C2698077

object_name: Breast cancer recurrent


subject: UMLS:C2698077

object_name: Colon cancer recurrent


subject: UMLS:C2698077

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C2698077

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C2698077

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C2698077

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C2698077

object_name: Melanoma recurrent


subject: UMLS:C2698077

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C2698077

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2698077

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2698077

object_name: Malignant neoplasm of stomach stage III


subject: UMLS:C2698077

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C2698077

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C2698077

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2698077

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C2698077

object_name: Malignant neoplasm of stomach stage IV


subject: UMLS:C2698077

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C2698077

object_name: Carcinoma breast stage IV


subject: UMLS:C2698077

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2698077

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C2698077

object_name: Stage III Colon Cancer AJCC v7


subject: UMLS:C2698077

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C2698077

object_name: Stage III Colon Cancer


subject: UMLS:C2698077

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C2698077

object_name: Stage IV Colon Cancer AJCC v6


subject: UMLS:C2698077

object_name: Stage IV Colon Cancer AJCC v7


subject: UMLS:C2698077

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C2698077

object_name: male breast carcinoma


subject: UMLS:C2698077

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C2698077

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C2698077

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C2698077

object_name: metastatic melanoma


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: Pancreatic carcinoma stage II


subject: CHEBI:499361

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: stage IV pancreatic cancer


subject: CHEBI:499361

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:499361

object_name: Pancreatic carcinoma stage III


subject: CHEBI:499361

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: extrahepatic bile duct carcinoma


subject: CHEBI:499361

object_name: malignant tumor of extrahepatic bile duct


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Nausea, CTCAE_5


subject: CHEBI:31348

object_name: Nausea


subject: CHEBI:31348

object_name: Nausea, CTCAE_3


subject: CHEBI:31348

object_name: Vomiting, CTCAE


subject: CHEBI:31348

object_name: Vomiting


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:190519

subject_name: beta-lactoglobulin

object_name: Muscle Atrophy


subject: CHEBI:10023

subject_name: Voriconazole

object_name: fusariosis


subject: CHEBI:10023

object_name: tinea unguium


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole


subject: PUBCHEM.COMPOUND:147912


subject: UMLS:C2745348

object_name: neurodegenerative disease


subject: UMLS:C2745348

object_name: Machado-Joseph disease


subject: UMLS:C2745348

object_name: multiple system atrophy


subject: UMLS:C2745348

object_name: synucleinopathy


subject: UMLS:C2745348

object_name: Ataxia


subject: UMLS:C2745348

object_name: atactic disorder


subject: UMLS:C2745348

object_name: Ataxia as late effect of cerebrovascular disease


subject: UMLS:C2745348

object_name: Dyssynergia


subject: UMLS:C2745348

object_name: Ataxia, CTCAE_5


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: tuberculosis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Gonarthrosis


subject: CHEBI:231594

subject_name: Norgestrel

object_name: chronic kidney disease


subject: CHEBI:231594

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:231594

object_name: CAKUT


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Maternity blues


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: chronic obstructive pulmonary disease


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: cystic fibrosis


subject: CHEBI:17561

subject_name: Cysteine


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: traumatic encephalopathy


subject: UMLS:C0279328

object_name: traumatic brain injury


subject: CHEBI:8499

subject_name: Propranolol

object_name: portal hypertension


subject: CHEBI:8499

object_name: Portal Hypertension, CTCAE


subject: CHEBI:63581

subject_name: Stavudine

object_name: AIDS


subject: CHEBI:63581

object_name: Kaposi Sarcoma


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63577


subject: CHEBI:63613

subject_name: Nevirapine


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: pancreatic neoplasm


subject: CHEBI:4466

object_name: exocrine pancreatic carcinoma


subject: CHEBI:4466

object_name: malignant pancreatic neoplasm


subject: CHEBI:4466

object_name: liver cancer


subject: CHEBI:4466

object_name: liver carcinoma


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:2948

subject_name: Azathioprine

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:2948

object_name: chronic myelomonocytic leukemia


subject: UMLS:C5555047

subject_name: DHODH Inhibitor JNJ-74856665

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5555047

object_name: acute myeloid leukemia


subject: UMLS:C5555047

object_name: Myelodysplasia


subject: UMLS:C5555047


subject: UMLS:C5555047


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C4733652

subject_name: FLT3 Inhibitor SKI-G-801


subject: UMLS:C4733652


subject: CHEBI:33322

subject_name: Rubidium

object_name: viral disease


subject: CHEBI:33322

object_name: Paramyxoviridae infectious disease


subject: CHEBI:90683

subject_name: Talmapimod

object_name: plasma cell myeloma


subject: UNII:X587FW0372

subject_name: Ketone Ester

object_name: alcohol abuse


subject: UNII:X587FW0372

object_name: alcohol dependence


subject: CHEBI:17290

subject_name: (S)-3-hydroxybutyric acid


subject: CHEBI:17290


subject: CHEBI:37054


subject: CHEBI:37054


subject: UMLS:C0106006


subject: UMLS:C0106006


subject: UMLS:C0360032

subject_name: EMLA Cream

object_name: Pregnant


subject: UNII:9013DUQ28K

subject_name: Anakinra

object_name: Community-Acquired Pneumonia


subject: UNII:9013DUQ28K

object_name: Hospital acquired pneumonia


subject: CHEBI:2663

subject_name: Amiodarone

object_name: atrial flutter


subject: CHEBI:2663

object_name: Atrial Flutter by ECG Finding


subject: CHEBI:2663

object_name: Atrial Flutter, CTCAE


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: atrial fibrillation


subject: UMLS:C0001645

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C0001645

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C0001645


subject: UMLS:C0001645


subject: UMLS:C0001645


subject: UNII:DFC121MXC3

subject_name: Pimodivir

object_name: Hepatic impairment


subject: UMLS:C2954669

subject_name: diosmiplex

object_name: Raynaud disease


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: Cardiovascular Risk


subject: PUBCHEM.COMPOUND:70105374

object_name: hypertension


subject: PUBCHEM.COMPOUND:70105374

object_name: Hypertension, CTCAE


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:32020


subject: CHEBI:32020


subject: CHEBI:32599

object_name: childhood onset asthma


subject: CHEBI:5959

subject_name: Irbesartan

object_name: myocardial ischemia


subject: CHEBI:5959

object_name: coronary atherosclerosis


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: PUBCHEM.COMPOUND:133604

subject_name: Collagen

object_name: pelvic pain on the left


subject: PUBCHEM.COMPOUND:133604

object_name: pelvic pain occurs with urination


subject: PUBCHEM.COMPOUND:133604

object_name: pelvic pain occurs with bowel movement


subject: PUBCHEM.COMPOUND:133604

object_name: pelvic pain decreasing in severity


subject: PUBCHEM.COMPOUND:133604

object_name: Pelvic pain female


subject: PUBCHEM.COMPOUND:133604

object_name: pelvic pain increasing in severity


subject: PUBCHEM.COMPOUND:133604

object_name: male pelvic pain


subject: PUBCHEM.COMPOUND:133604

object_name: pelvic pain to the rear


subject: PUBCHEM.COMPOUND:133604

object_name: pelvic pain on the right


subject: PUBCHEM.COMPOUND:133604

object_name: pelvic pain decreasing in frequency


subject: PUBCHEM.COMPOUND:133604

object_name: Pelvic pain


subject: PUBCHEM.COMPOUND:133604

object_name: Pelvic Pain, CTCAE 5.0


subject: PUBCHEM.COMPOUND:133604

object_name: pelvic pain causes awakening at night


subject: PUBCHEM.COMPOUND:133604

object_name: pelvic pain increasing in frequency


subject: PUBCHEM.COMPOUND:133604

object_name: pelvic pain occurs with intercourse


subject: PUBCHEM.COMPOUND:133604

object_name: pelvic pain in front


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: UMLS:C0009325

subject_name: collagen


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: CHEBI:95165

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: CHEBI:95165

object_name: FLT3 Tyrosine Kinase Domain Point Mutation


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:91464


subject: CHEBI:91464

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:91464


subject: CHEBI:63452

subject_name: Midostaurin


subject: CHEBI:63452


subject: CHEBI:63452


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: Anemia of pregnancy


subject: PR:000009978

subject_name: lactotransferrin


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: aortic valve calcification


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab


subject: UMLS:C1530450

subject_name: AMG 162


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:72370618

object_name: metabolic syndrome X


subject: PUBCHEM.COMPOUND:72370618

object_name: Abnormal renal physiology


subject: PUBCHEM.COMPOUND:72370618

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:72370618

object_name: hyperglycemia


subject: PUBCHEM.COMPOUND:72370618

object_name: Hyperglycemia, CTCAE


subject: PUBCHEM.COMPOUND:72370618

object_name: Glucose in blood specimen above reference range


subject: PUBCHEM.COMPOUND:72370618

object_name: Weight Gain


subject: PUBCHEM.COMPOUND:72370618

object_name: Weight Gain, CTCAE


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:90926


subject: PUBCHEM.COMPOUND:56998

object_name: Plasmodium falciparum malaria


subject: UMLS:C4722543

subject_name: Toll-like Receptor 4 Agonist GLA-SE


subject: UMLS:C4722544

subject_name: Glucopyranosyl Lipid Adjuvant-Stable Emulsion


subject: UMLS:C5907993

subject_name: CTPS1 Inhibitor STP938

object_name: essential thrombocythemia


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: GTOPDB:4934

subject_name: G-CSF

object_name: diffuse large B-cell lymphoma


subject: GTOPDB:4934


subject: GTOPDB:4934

object_name: primary mediastinal large B-cell lymphoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Adverse drug response


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:32660

subject_name: asparaginase

object_name: Childhood L2 Acute Lymphoblastic Leukemia


subject: CHEBI:32660

object_name: Childhood L1 Acute Lymphoblastic Leukemia


subject: CHEBI:32660

object_name: Childhood Non-T Non-B Acute Lymphoblastic Leukemia


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: T-cell childhood acute lymphocytic leukemia


subject: UNII:PVI5M0M1GW


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:45783


subject: CHEBI:45783


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:8382


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:46295

subject_name: Vardenafil

object_name: spinal cord injury


subject: CHEBI:31186

subject_name: Alfacalcidol

object_name: end stage renal failure


subject: CHEBI:31186

object_name: Chronic uremia


subject: CHEBI:125427


subject: CHEBI:125427


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: UNII:E39B3691TD

object_name: invasive aspergillosis


subject: UNII:E39B3691TD

object_name: Invasive pulmonary aspergillosis


subject: UMLS:C4309089


subject: UMLS:C4309089


subject: UMLS:C1871984

object_name: complex partial epilepsy


subject: UMLS:C1871984

object_name: epilepsy


subject: UMLS:C1871984

object_name: focal epilepsy


subject: CHEBI:4026

object_name: amyloidosis


subject: CHEBI:4027


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: UMLS:C4743433

subject_name: onabotulinum toxin A

object_name: Urinary Urgency


subject: CHEBI:7457

subject_name: Nalmefene

object_name: opiate dependence


subject: UMLS:C4329314

subject_name: Plamotamab

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4329314

object_name: B-cell non-Hodgkin lymphoma


subject: MESH:C579032

subject_name: yangzheng xiaoji

object_name: ovarian cancer


subject: MESH:C579032

object_name: ovarian neoplasm


subject: MESH:C579032

object_name: ovarian carcinoma


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:RJ1IW3B4QX

object_name: COPD, severe early onset


subject: UNII:RJ1IW3B4QX

object_name: COPD exacerbation


subject: UNII:RJ1IW3B4QX

object_name: airway disease


subject: UNII:RJ1IW3B4QX

object_name: immune system disorder


subject: UNII:RJ1IW3B4QX

object_name: copd bronchitis


subject: UMLS:C5544993

object_name: type 2 diabetes mellitus


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: gastric neoplasm


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: Waldenstrom macroglobulinemia


subject: UNII:W6F4FRQ5QC

subject_name: PULRODEMSTAT

object_name: small cell lung carcinoma


subject: UMLS:C4330526


subject: CHEBI:669

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:669

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:669

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:669

object_name: acute myeloid leukemia


subject: CHEBI:669

object_name: Intrachromosomal Amplification of Chromosome 21


subject: CHEBI:669

object_name: Somatic mutation


subject: CHEBI:669

object_name: Typified by somatic mosaicism


subject: CHEBI:669

object_name: CBL gene mutation


subject: CHEBI:669

object_name: PTPN11 gene mutation


subject: CHEBI:669

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:669

object_name: NRAS Gene Amplification


subject: CHEBI:669

object_name: Chromosome Aberrations


subject: CHEBI:669

object_name: chromosomal disorder


subject: CHEBI:669

object_name: acute lymphoblastic leukemia


subject: CHEBI:669

object_name: Neoplasm, Residual


subject: CHEBI:669

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:669

object_name: neurofibromatosis 1


subject: CHEBI:669

object_name: neurofibromatosis type 1


subject: CHEBI:669

object_name: fetal hemoglobin measurement


subject: CHEBI:669

object_name: Myelodysplasia


subject: CHEBI:669

object_name: Myelodysplasia, CTCAE


subject: CHEBI:669

object_name: acute leukemia


subject: CHEBI:669

object_name: central nervous system leukemia


subject: CHEBI:669

object_name: Chromosome 7, monosomy


subject: CHEBI:669

object_name: Cancer Remission


subject: CHEBI:669

object_name: Remission


subject: CHEBI:184492

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:184492

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:184492

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:184492

object_name: acute myeloid leukemia


subject: CHEBI:184492

object_name: Intrachromosomal Amplification of Chromosome 21


subject: CHEBI:184492

object_name: Somatic mutation


subject: CHEBI:184492

object_name: Typified by somatic mosaicism


subject: CHEBI:184492

object_name: CBL gene mutation


subject: CHEBI:184492

object_name: PTPN11 gene mutation


subject: CHEBI:184492

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:184492

object_name: NRAS Gene Amplification


subject: CHEBI:184492

object_name: Chromosome Aberrations


subject: CHEBI:184492

object_name: chromosomal disorder


subject: CHEBI:184492

object_name: acute lymphoblastic leukemia


subject: CHEBI:184492

object_name: Neoplasm, Residual


subject: CHEBI:184492

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:184492

object_name: neurofibromatosis 1


subject: CHEBI:184492

object_name: neurofibromatosis type 1


subject: CHEBI:184492

object_name: fetal hemoglobin measurement


subject: CHEBI:184492

object_name: Myelodysplasia


subject: CHEBI:184492

object_name: Myelodysplasia, CTCAE


subject: CHEBI:184492

object_name: acute leukemia


subject: CHEBI:184492

object_name: central nervous system leukemia


subject: CHEBI:184492

object_name: Chromosome 7, monosomy


subject: CHEBI:184492

object_name: Cancer Remission


subject: CHEBI:184492

object_name: Remission


subject: CHEBI:30216

subject_name: alpha-particle

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:30216

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:30216

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:30216

object_name: acute myeloid leukemia


subject: CHEBI:30216

object_name: Intrachromosomal Amplification of Chromosome 21


subject: CHEBI:30216

object_name: Somatic mutation


subject: CHEBI:30216

object_name: Typified by somatic mosaicism


subject: CHEBI:30216

object_name: CBL gene mutation


subject: CHEBI:30216

object_name: PTPN11 gene mutation


subject: CHEBI:30216

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:30216

object_name: NRAS Gene Amplification


subject: CHEBI:30216

object_name: Chromosome Aberrations


subject: CHEBI:30216

object_name: chromosomal disorder


subject: CHEBI:30216

object_name: acute lymphoblastic leukemia


subject: CHEBI:30216

object_name: Neoplasm, Residual


subject: CHEBI:30216

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:30216

object_name: neurofibromatosis 1


subject: CHEBI:30216

object_name: neurofibromatosis type 1


subject: CHEBI:30216

object_name: fetal hemoglobin measurement


subject: CHEBI:30216

object_name: Myelodysplasia


subject: CHEBI:30216

object_name: Myelodysplasia, CTCAE


subject: CHEBI:30216

object_name: acute leukemia


subject: CHEBI:30216

object_name: central nervous system leukemia


subject: CHEBI:30216

object_name: Chromosome 7, monosomy


subject: CHEBI:30216

object_name: Cancer Remission


subject: CHEBI:30216

object_name: Remission


subject: UMLS:C5400714

subject_name: ALPHA (substance)

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C5400714

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C5400714

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C5400714

object_name: acute myeloid leukemia


subject: UMLS:C5400714

object_name: Intrachromosomal Amplification of Chromosome 21


subject: UMLS:C5400714

object_name: Somatic mutation


subject: UMLS:C5400714

object_name: Typified by somatic mosaicism


subject: UMLS:C5400714

object_name: CBL gene mutation


subject: UMLS:C5400714

object_name: PTPN11 gene mutation


subject: UMLS:C5400714

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C5400714

object_name: NRAS Gene Amplification


subject: UMLS:C5400714

object_name: Chromosome Aberrations


subject: UMLS:C5400714

object_name: chromosomal disorder


subject: UMLS:C5400714

object_name: acute lymphoblastic leukemia


subject: UMLS:C5400714

object_name: Neoplasm, Residual


subject: UMLS:C5400714

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5400714

object_name: neurofibromatosis 1


subject: UMLS:C5400714

object_name: neurofibromatosis type 1


subject: UMLS:C5400714

object_name: fetal hemoglobin measurement


subject: UMLS:C5400714

object_name: Myelodysplasia


subject: UMLS:C5400714

object_name: Myelodysplasia, CTCAE


subject: UMLS:C5400714

object_name: acute leukemia


subject: UMLS:C5400714

object_name: central nervous system leukemia


subject: UMLS:C5400714

object_name: Chromosome 7, monosomy


subject: UMLS:C5400714

object_name: Cancer Remission


subject: UMLS:C5400714

object_name: Remission


subject: UNII:AC10C1L8VO

subject_name: alpha

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:AC10C1L8VO

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:AC10C1L8VO

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:AC10C1L8VO

object_name: acute myeloid leukemia


subject: UNII:AC10C1L8VO

object_name: Intrachromosomal Amplification of Chromosome 21


subject: UNII:AC10C1L8VO

object_name: Somatic mutation


subject: UNII:AC10C1L8VO

object_name: Typified by somatic mosaicism


subject: UNII:AC10C1L8VO

object_name: CBL gene mutation


subject: UNII:AC10C1L8VO

object_name: PTPN11 gene mutation


subject: UNII:AC10C1L8VO

object_name: juvenile myelomonocytic leukemia


subject: UNII:AC10C1L8VO

object_name: NRAS Gene Amplification


subject: UNII:AC10C1L8VO

object_name: Chromosome Aberrations


subject: UNII:AC10C1L8VO

object_name: chromosomal disorder


subject: UNII:AC10C1L8VO

object_name: acute lymphoblastic leukemia


subject: UNII:AC10C1L8VO

object_name: Neoplasm, Residual


subject: UNII:AC10C1L8VO

object_name: acute myeloid leukemia by FAB classification


subject: UNII:AC10C1L8VO

object_name: neurofibromatosis 1


subject: UNII:AC10C1L8VO

object_name: neurofibromatosis type 1


subject: UNII:AC10C1L8VO

object_name: fetal hemoglobin measurement


subject: UNII:AC10C1L8VO

object_name: Myelodysplasia


subject: UNII:AC10C1L8VO

object_name: Myelodysplasia, CTCAE


subject: UNII:AC10C1L8VO

object_name: acute leukemia


subject: UNII:AC10C1L8VO

object_name: central nervous system leukemia


subject: UNII:AC10C1L8VO

object_name: Chromosome 7, monosomy


subject: UNII:AC10C1L8VO

object_name: Cancer Remission


subject: UNII:AC10C1L8VO

object_name: Remission


subject: PR:000001067

subject_name: transient receptor potential cation channel TRPV1 isoform 1

object_name: hematopoietic and lymphoid cell neoplasm


subject: PR:000001067

object_name: hematopoietic and lymphoid system neoplasm


subject: PR:000001067

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PR:000001067

object_name: acute myeloid leukemia


subject: PR:000001067

object_name: Intrachromosomal Amplification of Chromosome 21


subject: PR:000001067

object_name: Somatic mutation


subject: PR:000001067

object_name: Typified by somatic mosaicism


subject: PR:000001067

object_name: CBL gene mutation


subject: PR:000001067

object_name: PTPN11 gene mutation


subject: PR:000001067

object_name: juvenile myelomonocytic leukemia


subject: PR:000001067

object_name: NRAS Gene Amplification


subject: PR:000001067

object_name: Chromosome Aberrations


subject: PR:000001067

object_name: chromosomal disorder


subject: PR:000001067

object_name: acute lymphoblastic leukemia


subject: PR:000001067

object_name: Neoplasm, Residual


subject: PR:000001067

object_name: acute myeloid leukemia by FAB classification


subject: PR:000001067

object_name: neurofibromatosis 1


subject: PR:000001067

object_name: neurofibromatosis type 1


subject: PR:000001067

object_name: fetal hemoglobin measurement


subject: PR:000001067

object_name: Myelodysplasia


subject: PR:000001067

object_name: Myelodysplasia, CTCAE


subject: PR:000001067

object_name: acute leukemia


subject: PR:000001067

object_name: central nervous system leukemia


subject: PR:000001067

object_name: Chromosome 7, monosomy


subject: PR:000001067

object_name: Cancer Remission


subject: PR:000001067

object_name: Remission


subject: CHEBI:174615

object_name: Intrachromosomal Amplification of Chromosome 21


subject: CHEBI:174615

object_name: Somatic mutation


subject: CHEBI:174615

object_name: Typified by somatic mosaicism


subject: CHEBI:174615

object_name: CBL gene mutation


subject: CHEBI:174615

object_name: PTPN11 gene mutation


subject: CHEBI:174615

object_name: NRAS Gene Amplification


subject: CHEBI:174615

object_name: Chromosome Aberrations


subject: CHEBI:174615

object_name: chromosomal disorder


subject: CHEBI:174615

object_name: Neoplasm, Residual


subject: CHEBI:174615

object_name: neurofibromatosis 1


subject: CHEBI:174615

object_name: neurofibromatosis type 1


subject: CHEBI:174615

object_name: fetal hemoglobin measurement


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:176724

subject_name: Etiracetam

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:176724

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:176724

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724

object_name: acute lymphoblastic leukemia


subject: CHEBI:176724


subject: CHEBI:176724

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724

object_name: Myelodysplasia


subject: CHEBI:176724

object_name: Myelodysplasia, CTCAE


subject: CHEBI:176724

object_name: acute leukemia


subject: CHEBI:176724

object_name: central nervous system leukemia


subject: CHEBI:176724

object_name: Chromosome 7, monosomy


subject: CHEBI:176724

object_name: Cancer Remission


subject: CHEBI:176724

object_name: Remission


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW

object_name: Intrachromosomal Amplification of Chromosome 21


subject: UNII:73HC18Y1LW

object_name: Somatic mutation


subject: UNII:73HC18Y1LW

object_name: Typified by somatic mosaicism


subject: UNII:73HC18Y1LW

object_name: CBL gene mutation


subject: UNII:73HC18Y1LW

object_name: PTPN11 gene mutation


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW

object_name: NRAS Gene Amplification


subject: UNII:73HC18Y1LW

object_name: Chromosome Aberrations


subject: UNII:73HC18Y1LW

object_name: chromosomal disorder


subject: UNII:73HC18Y1LW

object_name: acute lymphoblastic leukemia


subject: UNII:73HC18Y1LW

object_name: Neoplasm, Residual


subject: UNII:73HC18Y1LW

object_name: acute myeloid leukemia by FAB classification


subject: UNII:73HC18Y1LW

object_name: neurofibromatosis 1


subject: UNII:73HC18Y1LW

object_name: neurofibromatosis type 1


subject: UNII:73HC18Y1LW

object_name: fetal hemoglobin measurement


subject: UNII:73HC18Y1LW

object_name: Myelodysplasia


subject: UNII:73HC18Y1LW

object_name: Myelodysplasia, CTCAE


subject: UNII:73HC18Y1LW

object_name: acute leukemia


subject: UNII:73HC18Y1LW

object_name: central nervous system leukemia


subject: UNII:73HC18Y1LW

object_name: Chromosome 7, monosomy


subject: UNII:73HC18Y1LW

object_name: Cancer Remission


subject: UNII:73HC18Y1LW

object_name: Remission


subject: CHEBI:6437

subject_name: Levetiracetam

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:6437

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:6437

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:6437

object_name: Intrachromosomal Amplification of Chromosome 21


subject: CHEBI:6437

object_name: Somatic mutation


subject: CHEBI:6437

object_name: Typified by somatic mosaicism


subject: CHEBI:6437

object_name: CBL gene mutation


subject: CHEBI:6437

object_name: PTPN11 gene mutation


subject: CHEBI:6437

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:6437

object_name: NRAS Gene Amplification


subject: CHEBI:6437

object_name: Chromosome Aberrations


subject: CHEBI:6437

object_name: chromosomal disorder


subject: CHEBI:6437

object_name: acute lymphoblastic leukemia


subject: CHEBI:6437

object_name: Neoplasm, Residual


subject: CHEBI:6437

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:6437

object_name: neurofibromatosis 1


subject: CHEBI:6437

object_name: neurofibromatosis type 1


subject: CHEBI:6437

object_name: fetal hemoglobin measurement


subject: CHEBI:6437

object_name: Myelodysplasia


subject: CHEBI:6437

object_name: Myelodysplasia, CTCAE


subject: CHEBI:6437

object_name: acute leukemia


subject: CHEBI:6437

object_name: central nervous system leukemia


subject: CHEBI:6437

object_name: Chromosome 7, monosomy


subject: CHEBI:6437

object_name: Cancer Remission


subject: CHEBI:6437

object_name: Remission


subject: CHEBI:82339

subject_name: Merphalan

object_name: Intrachromosomal Amplification of Chromosome 21


subject: CHEBI:82339

object_name: Somatic mutation


subject: CHEBI:82339

object_name: Typified by somatic mosaicism


subject: CHEBI:82339

object_name: CBL gene mutation


subject: CHEBI:82339

object_name: PTPN11 gene mutation


subject: CHEBI:82339

object_name: NRAS Gene Amplification


subject: CHEBI:82339

object_name: Chromosome Aberrations


subject: CHEBI:82339

object_name: chromosomal disorder


subject: CHEBI:82339

object_name: Neoplasm, Residual


subject: CHEBI:82339

object_name: neurofibromatosis 1


subject: CHEBI:82339

object_name: neurofibromatosis type 1


subject: CHEBI:82339

object_name: fetal hemoglobin measurement


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:4F4X42SYQ6

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6

object_name: Myelodysplasia, CTCAE


subject: UNII:4F4X42SYQ6

object_name: acute leukemia


subject: UNII:4F4X42SYQ6

object_name: central nervous system leukemia


subject: UNII:4F4X42SYQ6

object_name: Chromosome 7, monosomy


subject: UNII:4F4X42SYQ6

object_name: Cancer Remission


subject: UNII:4F4X42SYQ6

object_name: Remission


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415

object_name: Intrachromosomal Amplification of Chromosome 21


subject: UMLS:C0295415

object_name: Somatic mutation


subject: UMLS:C0295415

object_name: Typified by somatic mosaicism


subject: UMLS:C0295415

object_name: CBL gene mutation


subject: UMLS:C0295415

object_name: PTPN11 gene mutation


subject: UMLS:C0295415

object_name: NRAS Gene Amplification


subject: UMLS:C0295415

object_name: Chromosome Aberrations


subject: UMLS:C0295415

object_name: chromosomal disorder


subject: UMLS:C0295415

object_name: Neoplasm, Residual


subject: UMLS:C0295415

object_name: neurofibromatosis 1


subject: UMLS:C0295415

object_name: neurofibromatosis type 1


subject: UMLS:C0295415

object_name: fetal hemoglobin measurement


subject: UMLS:C0295415

object_name: Myelodysplasia, CTCAE


subject: UMLS:C0295415

object_name: acute leukemia


subject: UMLS:C0295415

object_name: central nervous system leukemia


subject: UMLS:C0295415

object_name: Chromosome 7, monosomy


subject: UMLS:C0295415

object_name: Cancer Remission


subject: UMLS:C0295415

object_name: Remission


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: Intrachromosomal Amplification of Chromosome 21


subject: UNII:D7RD81HE4W

object_name: Somatic mutation


subject: UNII:D7RD81HE4W

object_name: Typified by somatic mosaicism


subject: UNII:D7RD81HE4W

object_name: CBL gene mutation


subject: UNII:D7RD81HE4W

object_name: PTPN11 gene mutation


subject: UNII:D7RD81HE4W

object_name: juvenile myelomonocytic leukemia


subject: UNII:D7RD81HE4W

object_name: NRAS Gene Amplification


subject: UNII:D7RD81HE4W

object_name: Chromosome Aberrations


subject: UNII:D7RD81HE4W

object_name: chromosomal disorder


subject: UNII:D7RD81HE4W

object_name: Neoplasm, Residual


subject: UNII:D7RD81HE4W

object_name: neurofibromatosis 1


subject: UNII:D7RD81HE4W

object_name: neurofibromatosis type 1


subject: UNII:D7RD81HE4W

object_name: fetal hemoglobin measurement


subject: UNII:D7RD81HE4W

object_name: Myelodysplasia, CTCAE


subject: UNII:D7RD81HE4W

object_name: acute leukemia


subject: UNII:D7RD81HE4W

object_name: central nervous system leukemia


subject: UNII:D7RD81HE4W

object_name: Chromosome 7, monosomy


subject: UNII:D7RD81HE4W

object_name: Cancer Remission


subject: UNII:D7RD81HE4W

object_name: Remission


subject: UMLS:C0359156

subject_name: Thymoglobulin

object_name: Intrachromosomal Amplification of Chromosome 21


subject: UMLS:C0359156

object_name: Somatic mutation


subject: UMLS:C0359156

object_name: Typified by somatic mosaicism


subject: UMLS:C0359156

object_name: CBL gene mutation


subject: UMLS:C0359156

object_name: PTPN11 gene mutation


subject: UMLS:C0359156

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C0359156

object_name: NRAS Gene Amplification


subject: UMLS:C0359156

object_name: Chromosome Aberrations


subject: UMLS:C0359156

object_name: chromosomal disorder


subject: UMLS:C0359156

object_name: Neoplasm, Residual


subject: UMLS:C0359156

object_name: neurofibromatosis 1


subject: UMLS:C0359156

object_name: neurofibromatosis type 1


subject: UMLS:C0359156

object_name: fetal hemoglobin measurement


subject: UMLS:C0359156

object_name: Myelodysplasia, CTCAE


subject: UMLS:C0359156

object_name: acute leukemia


subject: UMLS:C0359156

object_name: central nervous system leukemia


subject: UMLS:C0359156

object_name: Chromosome 7, monosomy


subject: UMLS:C0359156

object_name: Cancer Remission


subject: UMLS:C0359156

object_name: Remission


subject: UMLS:C4547233

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C4547233

object_name: obesity


subject: UMLS:C4547233

object_name: Obesity, CTCAE


subject: UMLS:C5854566

subject_name: NKp46/CD16/CD20/IL-2-variant-specific NK Cell Engager IPH6501

object_name: non-Hodgkin lymphoma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: hypospadias


subject: CHEBI:46195

object_name: Penile hypospadias


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:7852


subject: CHEBI:57694

object_name: Cardiometabolic Syndrome


subject: CHEBI:57694

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: UMLS:C0067044

subject_name: Mylanta

object_name: dyspepsia


subject: UMLS:C0067044

object_name: Dyspepsia, CTCAE


subject: UMLS:C0067044

object_name: Heartburn


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: fibrous dysplasia


subject: UMLS:C1530450

subject_name: AMG 162


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: Thumb osteoarthritis


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:135515

subject_name: Bendamustine

object_name: lung cancer


subject: CHEBI:135515

object_name: lung neoplasm


subject: CHEBI:135515

object_name: lung carcinoma


subject: CHEBI:151315

subject_name: Heparin

object_name: traumatic encephalopathy


subject: KEGG.COMPOUND:C00374


subject: PUBCHEM.COMPOUND:90488848

object_name: gout


subject: CHEBI:3892

subject_name: Corticotropin


subject: UMLS:C0718234

subject_name: Acthar


subject: UMLS:C2825093

subject_name: Adrenocorticotropic Hormone [EPC]


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: primary peritoneal carcinoma


subject: UNII:8M7YSN2KII

object_name: Primary Peritoneal Cancer


subject: UNII:8M7YSN2KII

object_name: fallopian tube carcinoma


subject: UNII:8M7YSN2KII

object_name: fallopian tube cancer


subject: UNII:8M7YSN2KII

object_name: ovarian carcinoma


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: prostate cancer


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: UMLS:C2347699

subject_name: Prostate Cancer Vaccine ONY-P1


subject: UMLS:C2347699


subject: CHEMBL.COMPOUND:CHEMBL2108918

subject_name: CHAMOMILE

object_name: generalized anxiety disorder


subject: CHEBI:66901

subject_name: Ivacaftor

object_name: chronic obstructive pulmonary disease


subject: CHEBI:47458

subject_name: Saracatinib

object_name: neoplasm


subject: UMLS:C1706679


subject: UMLS:C2757070

subject_name: Progesterone [EPC]

object_name: infertility


subject: CHEBI:60802

subject_name: ropivacaine

object_name: nerve compression syndrome


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: smoldering plasma cell myeloma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:32244

subject_name: Tolperisone hydrochloride

object_name: Spasm of back muscles


subject: CHEBI:32244

object_name: Muscle spasm


subject: CHEBI:32244

object_name: Hyperkinesia


subject: CHEBI:32244

object_name: Acute Pain


subject: CHEBI:32244

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:32244

object_name: Back pain


subject: CHEBI:32244

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:32244

object_name: back spasm upper back


subject: CHEBI:32244

object_name: Sprain of unspecified site of back


subject: CHEBI:32244

object_name: Strain of back muscle


subject: CHEBI:32244

object_name: Strain of tendon of back


subject: UMLS:C1564420

subject_name: Tolperisone Hydrochloride


subject: UMLS:C1564420


subject: UMLS:C1564420


subject: UMLS:C1564420


subject: UMLS:C1564420


subject: UMLS:C1564420


subject: UMLS:C1564420


subject: UMLS:C1564420


subject: UMLS:C1564420


subject: UMLS:C1564420


subject: UMLS:C1564420


subject: CHEBI:93835

subject_name: Tolperisone


subject: CHEBI:93835


subject: CHEBI:93835


subject: CHEBI:93835


subject: CHEBI:93835


subject: CHEBI:93835


subject: CHEBI:93835


subject: CHEBI:93835


subject: CHEBI:93835


subject: CHEBI:93835


subject: CHEBI:93835


subject: PUBCHEM.COMPOUND:42066809

subject_name: Capecitabine (Xeloda)

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:42066809

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:42066809

object_name: breast cancer


subject: UNII:9013DUQ28K

subject_name: Anakinra

object_name: rectal carcinoma


subject: UNII:9013DUQ28K

object_name: rectal cancer


subject: UNII:9013DUQ28K

object_name: Childhood Rectal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3137355

subject_name: VEPOLOXAMER

object_name: heart failure


subject: DRUGBANK:DB11333

subject_name: Poloxamer 188


subject: UMLS:C4722737

subject_name: AXS 05

object_name: Alzheimer disease type 1


subject: UMLS:C4722737

object_name: Alzheimer disease


subject: UMLS:C4722737

object_name: Agitation


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: uterine cancer


subject: UNII:2S9ZZM9Q9V

object_name: tumor of uterus


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: trigeminal neuralgia


subject: CHEBI:95021

subject_name: pemetrexed

object_name: cervical cancer


subject: CHEBI:95021

object_name: cervical carcinoma


subject: CHEBI:64356

subject_name: Pregabalin

object_name: urolithiasis


subject: CHEBI:64356

object_name: nephrolithiasis


subject: CHEBI:64356

object_name: Addiction


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: brain neoplasm


subject: UNII:M487QF2F4V

object_name: Solid Neoplasm


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: UMLS:C1321603


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:91400

subject_name: Afatinib

object_name: glioblastoma


subject: CHEBI:91400

object_name: Childhood Glioblastoma


subject: CHEBI:91400

object_name: adult glioblastoma


subject: CHEBI:91400

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:91400

object_name: Recurrent Glioblastoma


subject: CHEBI:91400

object_name: Recurrent disease


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839


subject: CHEBI:70839


subject: CHEBI:70839


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: UNII:19997EZ42I

subject_name: Ampreloxetine

object_name: myopathy, lactic acidosis, and sideroblastic anemia


subject: UNII:19997EZ42I

object_name: multiple system atrophy


subject: UNII:19997EZ42I

object_name: Parkinson disease


subject: UMLS:C2733644

subject_name: Black Seed Oil

object_name: obesity


subject: UMLS:C4721715

subject_name: Cuminum cyminum whole extract


subject: CHEBI:75929

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEMBL.COMPOUND:CHEMBL1237024

subject_name: SIPULEUCEL-T

object_name: Advanced prostate cancer


subject: UMLS:C0254772

object_name: type 2 diabetes mellitus


subject: UMLS:C0879624

object_name: Non-small cell lung cancer stage I


subject: UMLS:C0879624

object_name: Non-small cell lung cancer stage II


subject: UMLS:C0879624

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C0879624

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C0879624

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C0879624

object_name: Non-small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: Unexplained infertility


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: CHEBI:17026

subject_name: Progesterone


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:28429

subject_name: ampelopsin

object_name: alcohol-related disorders


subject: PUBCHEM.COMPOUND:131752975

subject_name: Ampelopsin D


subject: CHEBI:28917

subject_name: dihydromyricetin


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: Gastrointestinal dysmotility


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Recurrent Rectal Cancer


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: stage IVA rectal cancer


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: stage IVB rectal cancer


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Colon cancer recurrent


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: unspecified adult solid tumor, protocol specific


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: stage IVB colon cancer


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: stage IVA colon cancer


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Stage IVA Colon Cancer AJCC v8


subject: DRUGBANK:DB05801

object_name: Recurrent Rectal Cancer


subject: DRUGBANK:DB05801

object_name: stage IVA rectal cancer


subject: DRUGBANK:DB05801

object_name: Stage IVA Rectal Cancer AJCC v7


subject: DRUGBANK:DB05801

object_name: Stage IVA Rectal Cancer AJCC v8


subject: DRUGBANK:DB05801

object_name: Stage IVB Rectal Cancer AJCC v7


subject: DRUGBANK:DB05801

object_name: Stage IVB Rectal Cancer AJCC v8


subject: DRUGBANK:DB05801

object_name: stage IVB rectal cancer


subject: DRUGBANK:DB05801

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: DRUGBANK:DB05801

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: DRUGBANK:DB05801

object_name: Stage IIIC Colon Cancer AJCC v8


subject: DRUGBANK:DB05801

object_name: Stage IIIC Colon Cancer AJCC v7


subject: DRUGBANK:DB05801

object_name: Colon cancer recurrent


subject: DRUGBANK:DB05801

object_name: unspecified adult solid tumor, protocol specific


subject: DRUGBANK:DB05801

object_name: stage IVB colon cancer


subject: DRUGBANK:DB05801

object_name: Stage IVB Colon Cancer AJCC v7


subject: DRUGBANK:DB05801

object_name: Stage IVB Colon Cancer AJCC v8


subject: DRUGBANK:DB05801

object_name: stage IVA colon cancer


subject: DRUGBANK:DB05801

object_name: Stage IVA Colon Cancer AJCC v7


subject: DRUGBANK:DB05801

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: stage IVA rectal cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVA Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVA Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVB Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IVB Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: stage IVB rectal cancer


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:681569

subject_name: Clofarabine

object_name: B-cell neoplasm


subject: UNII:349552KRHK

subject_name: Simendan

object_name: Acute Kidney Insufficiency


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C0879624

object_name: non-small cell lung carcinoma


subject: CHEBI:42797

subject_name: Gabapentin

object_name: osteoarthritis, knee


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Fever


subject: GTOPDB:4942

object_name: Fever symptoms (finding)


subject: GTOPDB:4942

object_name: Fever, CTCAE


subject: GTOPDB:4942

object_name: Sepsis


subject: GTOPDB:4942

object_name: Sepsis, CTCAE


subject: GTOPDB:4942

object_name: leukopenia


subject: GTOPDB:4942

object_name: neutropenia


subject: GTOPDB:4942

object_name: breast neoplasm


subject: GTOPDB:4942

object_name: hematologic disorder


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: PUBCHEM.COMPOUND:11297617

subject_name: PEGAMOTECAN

object_name: gastroesophageal cancer


subject: PUBCHEM.COMPOUND:11297617

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:11297617

object_name: gastric cancer


subject: UNII:ZY7ZTE7LFH


subject: UNII:ZY7ZTE7LFH


subject: UNII:ZY7ZTE7LFH


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: neoplasm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: cervical adenosquamous carcinoma


subject: CHEBI:4026

object_name: pancreatic adenosquamous carcinoma


subject: CHEBI:4026

object_name: adenosquamous carcinoma


subject: CHEBI:4026

object_name: adenocarcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367

object_name: Metastatic non-small cell lung cancer


subject: PUBCHEM.COMPOUND:3367

object_name: squamous cell carcinoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:233362

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: Adult Central Nervous System Neoplasm


subject: UMLS:C0770694

object_name: Childhood Central Nervous System Neoplasm


subject: UMLS:C0770694

object_name: central nervous system neoplasm


subject: UMLS:C0770694

object_name: central nervous system cancer


subject: UMLS:C0770694

object_name: Malignant neoplasm of the central nervous system


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UNII:43K1W2T1M6

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:95341

subject_name: Baricitinib

object_name: acquired idiopathic inflammatory myopathy


subject: CHEBI:95341

object_name: idiopathic inflammatory myopathy


subject: MESH:C000716647

object_name: Sjogren-Larsson syndrome


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Lumbar facet joint syndrome


subject: UMLS:C0729203

subject_name: Omnipaque


subject: CHEBI:31709

subject_name: Iohexol


subject: UMLS:C5432265

subject_name: Goflikicept

object_name: pericarditis


subject: UMLS:C5432265

object_name: Pericarditis, CTCAE


subject: UMLS:C4329337

subject_name: TAB 001

object_name: Advanced Mucosal Melanoma


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: traumatic encephalopathy


subject: PUBCHEM.COMPOUND:6096882

object_name: traumatic brain injury


subject: PUBCHEM.COMPOUND:6096882

object_name: intracerebral hemorrhage


subject: PUBCHEM.COMPOUND:6096882

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:6096882

object_name: subarachnoid hemorrhage


subject: PUBCHEM.COMPOUND:6096882

object_name: Acute anoxic encephalopathy


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: DRUGBANK:DB16538

subject_name: Bifidobacterium bifidum

object_name: digestive system disorder


subject: DRUGBANK:DB16538

object_name: acute lymphoblastic leukemia


subject: DRUGBANK:DB16541

subject_name: Lactobacillus casei


subject: DRUGBANK:DB16541


subject: DRUGBANK:DB19282

subject_name: Lacticaseibacillus rhamnosus


subject: DRUGBANK:DB19282


subject: CHEBI:30006

subject_name: L-leucine residue

object_name: chronic obstructive pulmonary disease


subject: CHEBI:25017

subject_name: leucine


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: Arterial Stiffness


subject: CHEBI:31932

subject_name: olmesartan


subject: CHEBI:42797

subject_name: Gabapentin

object_name: musculoskeletal system disorder


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: childhood onset asthma


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Traveler's diarrhea


subject: CHEBI:50733

subject_name: nutraceutical

object_name: biliary tract neoplasm


subject: CHEBI:50733

object_name: liver neoplasm


subject: CHEBI:50733

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: CHEBI:50733

object_name: colorectal neoplasm


subject: UNII:7T1PY32ZPH

subject_name: Cirtuvivint

object_name: ovarian endometrioid adenocarcinoma


subject: UNII:7T1PY32ZPH

object_name: fallopian tube carcinoma


subject: UNII:7T1PY32ZPH

object_name: fallopian tube cancer


subject: UNII:7T1PY32ZPH

object_name: primary peritoneal carcinoma


subject: UNII:7T1PY32ZPH

object_name: Primary Peritoneal Cancer


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:64073

object_name: schizophrenia


subject: CHEBI:64073

object_name: schizoaffective disorder


subject: CHEBI:64073

object_name: schizophrenia 18


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: UNII:9P1872D4OL


subject: UNII:9P1872D4OL


subject: CHEBI:49005

subject_name: Deferasirox

object_name: postmenopausal osteoporosis


subject: CHEBI:72296

subject_name: Apixaban

object_name: neoplasm


subject: PR:000023306

object_name: Esophageal Anastomotic Leakage


subject: PR:000023306

object_name: Esophageal Anastomotic Leak, CTCAE


subject: UniProtKB:P0AF12

subject_name: MTNN_ECOLI 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (sprot)


subject: UniProtKB:P0AF12


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE

object_name: Vulvovaginal Atrophy


subject: CHEBI:3374

subject_name: Capsaicin

object_name: end stage renal failure


subject: CHEBI:3374

object_name: Chronic uremia


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: Immunocompromised Host


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UMLS:C1328719

subject_name: OSI 211

object_name: small cell carcinoma


subject: UMLS:C1328719

object_name: small cell lung carcinoma


subject: UMLS:C0796638

subject_name: Lurtotecan Liposome


subject: UMLS:C0796638


subject: GTOPDB:13796

subject_name: serplulimab

object_name: carcinoma of esophagus


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: CHEBI:90942

subject_name: Ixazomib

object_name: B-cell neoplasm


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: Postoperative Complications


subject: GTOPDB:4923

object_name: Varicose Ulcer


subject: GTOPDB:4923

object_name: type 2 diabetes mellitus


subject: GTOPDB:4923

object_name: Diabetes


subject: GTOPDB:4923

object_name: diabetes mellitus


subject: UMLS:C0079349

subject_name: fibroblast growth factor-1


subject: UMLS:C0079349


subject: UMLS:C0079349


subject: UMLS:C0079349


subject: UMLS:C1522455

subject_name: Recombinant Fibroblast Growth Factor 1


subject: UMLS:C1522455


subject: UMLS:C1522455


subject: UMLS:C1522455


subject: PR:000007479

subject_name: fibroblast growth factor 1


subject: PR:000007479


subject: PR:000007479


subject: PR:000007479


subject: CHEBI:52717

subject_name: Bortezomib

object_name: peripheral nervous system disorder


subject: CHEBI:52717

object_name: neuropathy


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX

object_name: heparin-induced thrombocytopenia


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:229906

object_name: inherited lipid metabolism disorder


subject: CHEBI:229906

object_name: Dyslipidemia


subject: PUBCHEM.COMPOUND:22175537

subject_name: Lapaquistat acetate


subject: PUBCHEM.COMPOUND:22175537


subject: UMLS:C2825674

subject_name: Lapaquistat Acetate


subject: UMLS:C2825674


subject: UNII:97I1C92E55

subject_name: CEFIXIME

object_name: gonorrhea


subject: CHEBI:472657

subject_name: Cefixime


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:33325

subject_name: radium atom

object_name: breast neoplasm


subject: UMLS:C3827153


subject: DRUGBANK:DB17952

object_name: Papillon-Lefevre disease


subject: CHEMBL.COMPOUND:CHEMBL2107911

subject_name: ONERCEPT

object_name: psoriatic arthritis


subject: UMLS:C1100611

subject_name: Onercept


subject: UNII:P0R64C4CR9

subject_name: PIXANTRONE DIMALEATE

object_name: Childhood Breast Carcinoma


subject: UNII:P0R64C4CR9

object_name: breast carcinoma


subject: UNII:P0R64C4CR9

object_name: breast cancer


subject: CHEBI:135945

subject_name: Pixantrone


subject: CHEBI:135945


subject: CHEBI:135945


subject: UMLS:C2826149

subject_name: Pixantrone dimaleate


subject: UMLS:C2826149


subject: UMLS:C2826149


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate

object_name: infertility


subject: CHEBI:15414

subject_name: Adomet

object_name: Abdominal pain


subject: CHEBI:15414

object_name: Abdominal Pain, CTCAE


subject: UMLS:C3696061

subject_name: saffron extract

object_name: xerophthalmia


subject: UMLS:C3696061

object_name: dry eye syndrome


subject: UMLS:C3696061

object_name: Dry Eye Syndrome, CTCAE


subject: UMLS:C1446433

subject_name: Crocus sativus antigen


subject: UMLS:C1446433


subject: UMLS:C1446433


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Spinal Neoplasm


subject: CHEBI:49603

object_name: brain neoplasm


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C2346514

subject_name: Intranasal Ketamine

object_name: cancer


subject: UMLS:C2346514

object_name: neoplasm


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: Inflammatory carcinoma of breast recurrent


subject: MESH:C000629782

object_name: Breast cancer recurrent


subject: MESH:C000629782

object_name: Inflammatory carcinoma of breast stage IV


subject: MESH:C000629782

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: MESH:C000629782

object_name: malignant neoplasm of chest wall


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UMLS:C5442133

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:6129

subject_name: Ketorolac

object_name: paraphimosis


subject: CHEBI:6129

object_name: balanitis


subject: CHEBI:6129

object_name: Acquired phimosis


subject: CHEBI:6129

object_name: phimosis


subject: CHEBI:4672

subject_name: Docetaxel

object_name: peritoneal carcinomatosis


subject: CHEBI:4672

object_name: Metastatic gastric adenocarcinoma


subject: CHEBI:4672

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:724125

subject_name: Methyl aminolevulinate

object_name: actinic keratosis


subject: CHEBI:195181

subject_name: Alanylalanine

object_name: Childhood Breast Carcinoma


subject: CHEBI:195181

object_name: breast carcinoma


subject: CHEBI:195181

object_name: breast cancer


subject: CHEBI:15843

subject_name: Arachidonate


subject: CHEBI:15843


subject: CHEBI:15843


subject: UMLS:C0002520

subject_name: Amino Acids


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: CHEMBL.COMPOUND:CHEMBL4297817


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: B-cell adult acute lymphocytic leukemia


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: periodontitis


subject: UNII:XI179PG9LV

object_name: treatment resistant depression


subject: UNII:XI179PG9LV


subject: UNII:XI179PG9LV

object_name: major depressive disorder


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Breast cancer recurrent


subject: CHEBI:71219

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:71219

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: atopic eczema


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: hypertrophic cardiomyopathy


subject: PUBCHEM.COMPOUND:54214995

object_name: Hypertrophic cardiomyopathy without obstruction


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: UMLS:C0281722

subject_name: gp100 Antigen

object_name: stage IB melanoma


subject: UMLS:C0281722

object_name: stage IA melanoma


subject: UMLS:C0281722

object_name: Stage IIC Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0281722

object_name: stage IIA melanoma


subject: UMLS:C0281722

object_name: Stage IIA Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0599934

subject_name: Vaccines, Peptide

object_name: Melanoma recurrent


subject: UMLS:C0599934


subject: UMLS:C0599934


subject: UMLS:C0599934

object_name: stage IIC melanoma


subject: UMLS:C0599934


subject: UMLS:C0599934


subject: UMLS:C0599934


subject: UMLS:C0599934

object_name: stage IIB melanoma


subject: UMLS:C0599934

object_name: stage IIIB melanoma


subject: UMLS:C0599934

object_name: stage IIIC melanoma


subject: UMLS:C0599934

object_name: stage IIIA melanoma


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Adult Myelodysplastic Syndrome


subject: UNII:5TAA004E22

object_name: childhood myelodysplastic syndrome


subject: UNII:5TAA004E22

object_name: Myelodysplastic Syndrome, CTCAE


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:134703

subject_name: Fluciclovine (18F)

object_name: bladder tumor


subject: CHEBI:134703

object_name: urinary bladder carcinoma


subject: CHEBI:134703

object_name: urinary bladder cancer


subject: CHEBI:134703

object_name: childhood bladder carcinoma


subject: CHEBI:134703

object_name: urothelial carcinoma


subject: CHEBI:134703

object_name: transitional cell carcinoma


subject: UMLS:C5435115

object_name: rheumatoid arthritis


subject: CHEBI:4672

subject_name: Docetaxel

object_name: pediatric osteosarcoma


subject: CHEBI:4672

object_name: Osteosarcoma


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: myeloid neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: diabetic retinopathy


subject: GTOPDB:8931

object_name: breast neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297556


subject: UMLS:C2827711


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:31355

object_name: liver failure


subject: CHEBI:31355

object_name: kidney failure


subject: CHEBI:31355

object_name: Renal Failure, CTCAE


subject: CHEBI:31355

object_name: Unresectable Malignant Neoplasm


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:62880

subject_name: Veliparib


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880

object_name: endometrial carcinoma


subject: CHEBI:62880

object_name: head and neck cancer


subject: CHEBI:62880


subject: CHEBI:62880

object_name: testicular cancer


subject: CHEBI:62880

object_name: cancer of unknown primary site


subject: CHEBI:62880

object_name: urothelial carcinoma


subject: CHEBI:62880

object_name: transitional cell carcinoma


subject: CHEBI:62880

object_name: carcinoma of esophagus


subject: CHEBI:62880

object_name: ovarian cancer


subject: CHEBI:62880

object_name: ovarian carcinoma


subject: CHEBI:62880

object_name: malignant epithelial tumor of ovary


subject: CHEBI:62880

object_name: lung carcinoma


subject: CHEBI:62880

object_name: melanoma


subject: CHEBI:47657

subject_name: Roflumilast

object_name: alopecia


subject: CHEBI:47657

object_name: Alopecia, CTCAE


subject: CHEBI:47657

object_name: alopecia areata


subject: CHEBI:47657

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:47657

object_name: obesity


subject: CHEBI:47657

object_name: Obesity, CTCAE


subject: CHEBI:47657

object_name: Prediabetes


subject: UMLS:C5447410

subject_name: Complement Factor D Inhibitor BCX9930

object_name: IgA Nephropathy


subject: UMLS:C5447410

object_name: Complement 3 Glomerulopathies


subject: UMLS:C5447410

object_name: membranous glomerulonephritis


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: glaucoma


subject: CHEBI:9667

object_name: Glaucoma, CTCAE


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: gestational diabetes


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: PR:000001786

object_name: coronary artery disorder


subject: PR:000001786

object_name: coronary atherosclerosis


subject: PR:000001786

object_name: myocardial ischemia


subject: CHEBI:63632

subject_name: Topotecan

object_name: Recurrent Retinoblastoma


subject: UNII:GG81XF45C2

object_name: type 2 diabetes mellitus


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Harmful pattern of use of methamphetamine


subject: CHEBI:28939

object_name: Harmful pattern of substance use


subject: CHEBI:28939

object_name: substance abuse


subject: PUBCHEM.COMPOUND:135582802

subject_name: CEFTOBIPROLE MEDOCARIL

object_name: neonatal sepsis


subject: PUBCHEM.COMPOUND:135582802

object_name: Bacterial sepsis of newborn


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: CHEBI:140407

subject_name: Ceftobiprole


subject: CHEBI:140407


subject: CHEBI:77260

subject_name: Omeprazole

object_name: Peptic Ulcer Hemorrhage


subject: CHEBI:77260

object_name: Marginal ulcer


subject: DRUGBANK:DB08937

object_name: rectal carcinoma


subject: DRUGBANK:DB08937

object_name: rectal cancer


subject: DRUGBANK:DB08937

object_name: Childhood Rectal Carcinoma


subject: CHEBI:90876

subject_name: Lonsurf


subject: CHEBI:90876


subject: CHEBI:90876


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Mesothelioma


subject: CHEBI:52717

object_name: mesothelial neoplasm


subject: CHEBI:52717

object_name: malignant mesothelioma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Depressed mood


subject: CHEBI:46245

object_name: Cancer patients and suicide and depression


subject: CHEBI:46245

object_name: Depressed - symptom


subject: CHEBI:46245

object_name: Depression, CTCAE


subject: CHEBI:46245

object_name: major affective disorder 4


subject: CHEBI:46245

object_name: major affective disorder 7


subject: CHEBI:46245

object_name: major affective disorder 6


subject: CHEBI:46245

object_name: major affective disorder 2


subject: CHEBI:46245

object_name: major affective disorder 8


subject: CHEBI:46245

object_name: major affective disorder 9


subject: CHEBI:46245

object_name: major affective disorder 1


subject: CHEBI:46245

object_name: major affective disorder 5


subject: UMLS:C0733688

object_name: glioblastoma


subject: UMLS:C0733688

object_name: Childhood Glioblastoma


subject: UMLS:C0733688

object_name: adult glioblastoma


subject: UMLS:C0733688

object_name: Adult Gliosarcoma


subject: UMLS:C0733688

object_name: gliosarcoma


subject: UMLS:C0733688

object_name: Childhood Gliosarcoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Abdominal pain


subject: CHEBI:50275

object_name: Abdominal Pain, CTCAE